Phoenix Life Sciences International Announces Giving Pledge Commitment and Launch of The Global Health Initiative with Kylie
April 11 2019 - 9:00AM
InvestorsHub NewsWire
Phoenix Life
Sciences International Announces Giving Pledge Commitment and
Launch of The Global Health Initiative with Kylie O’Brien
Ph.D.
DENVER, CO -- April
11, 2019 -- InvestorsHub NewsWire -- Phoenix Life
Sciences International Limited (OTC: PLSI) (“Phoenix Life” or
the “Company”), an adaptive healthcare solutions company, today
announced the launch of The Global Health
Initiative (“GHI”, the
“Foundation”) and the appointment of Dr. Kylie O’Brien as Chief
Executive Officer of the Foundation, commencing the next chapter of
the founders’ vision of the Company.
The Global Health
Initiative is an independent non-profit foundation and public
charity that combines significant investment, research partnership
and a commitment by the founders of Phoenix Life to
The Giving Pledge, investing 50% of
their holdings in the Company and their future dividends to
philanthropic support for creating change in global health. The
Giving Pledge is a commitment by the world's wealthiest individuals
and families to dedicate the majority of their wealth to giving
back.
“We see The Global
Health Initiative as an opportunity to set an example for others
from the cannabis industry to give back to their communities,
research, education and to provide access to those in need,” said
Phoenix Life CEO Martin Tindall. “We are proud to be the founding
benefactor to create The Global Health
Initiative to be a catalyst for
change.”
As part of launching The Global Health
Initiative, Kylie O’Brien, Ph.D. has been appointed as Chief
Executive Officer of the foundation. O’Brien holds a Master of
Public Health, Bachelor of Applied Science in Chinese Medicine,
Bachelor of Science in Optometry, Graduate Certificate of Tertiary
Education and a Ph.D. in Chinese Medicine. As an advocate for
medical cannabis, she developed Australia’s first course in medical
cannabis to receive Category 1 Continuing Professional Development
points with the Royal Australasian College of General
Practitioners.
O’Brien also created the pathway for
Australian doctors to become authorized prescribers of medicinal
cannabis under the Therapeutic Goods Administration’s (“TGA”)
Authorized Prescriber Scheme. Recently, she was appointed to the
TGA’s Advisory Committee for Complementary Medicines by the
Australian Federal Minister of Health and reappointed to the
Australian government’s Tertiary Education Quality and Standards
Agency’s Expert Panel.
She has a reputation as a highly-regarded
international leader among medical professionals. She serves as a
Council Member for the Specialty Committee of Cancer Rehabilitation
and was also on the Standardization Committee of the World
Federation of Chinese Medicine Societies. She has spoken about
integrative oncology at medical conferences in Australia, China,
and Turkey. She was invited to a roundtable which included members
of the Malaysian government to discuss policy for decriminalizing
hemp and introduce it as an agricultural crop within the country.
Her first book, A Clinician’s Guide to Integrative Oncology, was
published by Springer in the US in 2017.
“I have dedicated my career to raising
awareness for treatment alternatives within the international
health community and look forward to helping expand the global
knowledge on medicinal cannabis while helping communities in need
gain access to it,” said Global Health Initiative CEO Kylie
O’Brien, Ph.D. “I’m very humbled by the
Tindall family and Phoenix Life’s generosity and I’m excited to see
how we can mutually benefit each other’s
efforts.”
“Cannabis is
currently undervalued and under-researched in today’s healthcare
systems and we hope to be able to form meaningful relationships
with companies like Phoenix Life and change the way people utilize
it as a viable healthcare treatment option,” concluded Dr.
O’Brien.
###
About The Giving
Pledge
The Giving Pledge
is a campaign to encourage wealthy people to contribute a majority
of their wealth to philanthropic causes. As of 2019, the pledge has
187 signatories, either individuals or couples, from 22 countries.
Most of the signatories of the pledge are billionaires, and their
pledges total over $365 billion.
To learn more
about The Giving Pledge, please visit https://givingpledge.org.
About The Global
Health Initiative
The Global
Health Initiative is a public charity organized in the United
States in Colorado and in Australia. The organization’s efforts are
focused on addressing local and global health and social issues
affecting children and families. By developing strategic
partnerships with government and health officials, wellness
organizations and supportive community members,
the Global Health
Initiative aims to create a
foundation for community, research, education, access, training and
empowerment.
To learn more
about The Global Health Initiative, please visit
http://ghi.life
About Phoenix Life
Sciences International
Limited
Phoenix Life
Sciences International Limited is an adaptive healthcare solutions
company. Our business is to advance research and integrate programs
and manufacturing of products that target and treat diabetes, pain,
cancer, and address psychological, neurological, autoimmune and
sleep disorders. We strive to create partnerships and integrate
these programs for human health into communities worldwide as part
of our Global Health Initiative.
To learn more about
Phoenix Life Sciences International, please
visit https://phoenixlife.co/
FORWARD-LOOKING
STATEMENTS
Information
contained in this press release regarding Phoenix Life Sciences
International, Limited and its subsidiaries, (the “Companies”) may
constitute forward-looking statements or statements which may be
deemed or construed to be forward-looking statements. The words
“plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”,
“expect”, “should”, “believe,” and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to, known and unknown risks,
uncertainties and other factors which could cause the Company’s
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and other
factors are more fully discussed in the Company’s filings with the
U.S. Securities and Exchange Commission. All forward-looking
statements attributable to the Companies herein are expressly
qualified in their entirety by the above-mentioned cautionary
statement. The Companies disclaim any obligation to update
forward-looking statements contained in this press release, except
as may be required by law.
FOOD AND DRUG
ADMINISTRATION (FDA)
DISCLOSURE
These statements
have not been evaluated by the FDA and therefore the products sold
by Phoenix Life Sciences International are not available in the
U.S.
LEGAL
DISCLOSURE
Phoenix Life
Sciences International does not sell or distribute any products in
the United States that are in violation of the United States
Controlled Substances Act (US.CSA). This company does not grow,
sell, and distribute cannabis-based products in the United States
and is solely involved with the legal distribution of medical
cannabis-based products within certain international markets
outside of the United States.
Investor
Contact:
Phone:
1.888.717.5655 or international
+1.720.699.7222
E-mail: investor.relations@phoenixlife.co
Media
Contact:
Kathryn
Reinhardt
CMW
Media
Kathryn@cmwmedia.com
619-972-3089
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Sep 2023 to Sep 2024